Document complet  |  Dérouler chapitre  |  Etendre sommaire  |  Version HTML imprimable
Operational Guide for National Tuberculosis Control Programmes on the Introduction and Use of Fixed-Dose Combination Drugs
(2002; 81 pages) Voir le document au format PDF
Table des matières
Afficher le documentACKNOWLEDGEMENTS
Afficher le documentLIST OF ACRONYMS AND ABBREVIATIONS
Afficher le documentPREFACE
Afficher le documentKEY POINTS
Ouvrir ce répertoire et afficher son contenu1. INTRODUCTION
Ouvrir ce répertoire et afficher son contenu2. PROGRAMMATIC AND MANAGERIAL REQUIREMENTS FOR FDCS
Ouvrir ce répertoire et afficher son contenu3. FDC DRUG MANAGEMENT
Ouvrir ce répertoire et afficher son contenu4. ENSURING THE QUALITY OF FDC DRUGS
Ouvrir ce répertoire et afficher son contenu5. HOW TO INTRODUCE AND CHANGE OVER TO A REGIMEN WITH 4-DRUG FDCS/2-DRUG FDCS: PLANNING AND IMPLEMENTING A "SCENARIO"
Afficher le documentAnnex 1. Glossary and use of terms
Afficher le documentAnnex 2. WHO Certification Scheme - Model Certificate of a Pharmaceutical Product1
Afficher le documentAnnex 3. WHO Certification Scheme - Model Batch Certificate of a Pharmaceutical Product
Afficher le documentAnnex 4. Example of an order form for anti-TB drugs for treatment facilities
Afficher le documentAnnex 5. Steps in the quantification of anti-TB drugs using consumption-based information
Afficher le documentAnnex 6. Suggested reading
Afficher le documentRequest for feedback on the guide
 

Operational Guide for National Tuberculosis Control Programmes on the Introduction and Use of Fixed-Dose Combination Drugs

WHO/CDS/TB/2002.308 - WHO/EDM/PAR/2002.6

WORLD HEALTH ORGANIZATION
2002

Writing Group

S. Phanouvong 1
H. Vrakking 2
L. Blanc 3
E. Wondemagegnehu 4
T. Moore 5
L. Rägo 6
J. Mboussa 7
P. Norval 8
R. Matji 9

1 Technical Officer, Focal Point for Access to Quality Anti-TB Medicines, Department of Essential Drugs and Medicines Policy and Stop TB Department (STB), WHO

2 Technical Officer, Royal Netherlands Anti-Tuberculosis Association (KNCV), The Hague, Netherlands

3 Medical Officer, Tuberculosis Strategy and Operations (TBS), Stop TB Department, WHO

4 Technical Officer, Department of Essential Drugs and Medicines Policy, WHO

5 Senior Programme Associate, Management Sciences for Health and Stop TB Department, Global TB Drug Facility, WHO

6 Team Coordinator, Quality Assurance and Safety: Medicines, Department of Essential Drugs and Medicines Policy, WHO

7 Director, Anti-tuberculosis Programme, Brazzaville, Congo.

8 Tuberculosis Expert, Ministry of Health, France

9 Manager, National Tuberculosis Control Programme, South Africa

 

vers la section suivante
 
 
Le Portail d'information - Médicaments essentiels et produits de santé a été conçu et est maintenu par l'ONG Human Info. Dernière mise à jour: le 29 octobre 2018